紫杉醇是一种常用于治疗乳腺癌和卵巢癌的化疗药物，但是，随着用药时间的延长，一些肿瘤可以对其产生抗药性，而又开始生长了。
Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again.
目的探讨肿瘤标记物在卵巢癌的诊断和预后判断方面的价值。
Objective To study the values of tumor markers in the diagnosis and prognosis of ovarian tumor.
最近研究者们发现TEM1可作为与肿瘤生长相关的血管细胞的一个特异性的遗传学标记物，该发现可能有助于卵巢癌的诊断和治疗。
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.
这篇论文表明肿瘤中高表达的IL - 8与卵巢癌患者晚期肿瘤和早期死亡相关联。
The paper demonstrates that high IL-8 expression in tumors is associated with advanced tumor stage and earlier death for ovarian cancer patients.
同样，在卵巢癌小鼠模型中，抑制应激和相关的去甲肾上腺素和肾上腺素增加可防止肿瘤细胞发生失巢凋亡，从而促进肿瘤生长。
Similarly, in a mouse model of ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth.
目前卵巢癌标准治疗手段通常包括手术切除肿瘤，然后进行化疗。
Standard therapy for ovarian cancer now usually involves surgery to remove the tumor, followed by chemotherapy, which is initially effective but not curative.
这些新发现提示IGF2能够成为卵巢癌的治疗靶点，特别是对那些对紫杉醇耐药的肿瘤。
Such novel findings suggest that IGF2 represents a therapeutic target in ovarian cancer, particularly in the setting of Taxol resistance.
为了鉴定AKT1基因突变，研究人员共筛选了150份肿瘤样本，其中乳腺癌、直结肠癌和卵巢癌各50份。
To identify the AKT1 mutation, the researchers analyzed 150 tumor samples from patients with either breast, colorectal or ovarian cancer (50 samples from each tumor type).
结论CA125不只是卵巢癌的指标，也是一种广谱肿瘤标志物，并且肝硬化等良性疾病也有较高的阳性率，可作为健康体检中筛选异常人群的指标。
Conclusion: CA125 is not only a marker for ovarian cancer, but a broad-spectrum tumor marker. There are higher positive rates of CA125 in some benign diseases including hepatocirrhosis.
卵巢癌是妇科第二最常见妇科恶性肿瘤，但却是妇科癌症最常见的死亡原因，也是女性第五最常见癌症。
Ovarian cancer is the second most common gynecologic malignancy, but the most common cause of death among women who develop gynecologic cancer, and it is the fifth most common cancer in females.
目的研究多种肿瘤标志物蛋白芯片检测系统对卵巢癌的诊断价值。
Objective To investigate the diagnostic value of multi-tumor marker protein biochip detective system in the diagnosis of ovarian cancer.
方法建立人卵巢癌裸鼠动物模型，检测腺病毒介导的人血管抑素基因对肿瘤生长的抑制作用。
Methods A human ovarian cancer model using a nude mice was built to test the suppressive effect of human angiostatin gene mediated by adenovirus on the tumor growth.
国际肿瘤研究机构说，每年世界上新发现卵巢癌要超过190,000例。
Worldwide there are more than 190,000 new cases of ovarian cancer a year, the International Agency for Research on cancer says.
EGFR在良性卵巢肿瘤组织中的阳性表达率分别为40.0%，在卵巢癌组织中的阳性表达率为80.0%；
The positive rate of EGFR was 40.0% in ovarian benign tumor, and was 80.0% in ovarian cancer.
结论：CT与血清肿瘤标记物联检可提高对卵巢癌的诊断敏感性和临床分期符合率。
Conclusion: the combined application of ct and serum tumor markers in ovarian carcinoma detection could improve the sensitivity of diagnosis and its consistency with clinical staging.
目的：提高治疗卵巢癌的疗效，探讨新的肿瘤生物治疗方法。
To study on enhancement of the effect of biotherapy to ovarian carcinoma: a new method for treatment of cancer.
目的探索血清肿瘤标志物联合检测在卵巢癌诊断中的应用价值。
Objective To explore value of the serum tumor markers in early stage diagnosis of ovarian cancer.
检测卵巢癌的新方法可以明显弥补那些有百分之七十的病人只有在肿瘤长大或播散时才能诊断的缺陷。
A new way of detecting ovarian cancer could make a significant dent in this disease, where 70 percent of patients are diagnosed after the tumor has grown large or spread.
卵巢癌：卵巢的恶性肿瘤。
结论理想的肿瘤细胞减灭术对晚期及复发卵巢癌是安全可行的。
Conclusions Maximum cytoreductive surgery is feasible and effective for advanced and recurrent ovarian cancer.
方法用ELISA法分别检测卵巢良性肿瘤和卵巢癌患者术前及化疗前血清CA125和TPS水平。
Methods Serum levers of CA125 and TPS in patients with benign ovary tumor and patients with ovary cancer were measured by ELISA.
卵巢癌是恶性度最高的妇科肿瘤之一，由于手术和化疗的不尽人意，基因治疗是当今肿瘤研究的热点。
Ovarian cancer is one of the most malignant tumors in women. Gene therapy is the hot spot in tumor research because of the low efficiency of the operation and chemical therapy.
结果显示：卵巢癌组与良性肿瘤组和对照组相比，三项标志物的血清含量有显著性差异（P<0．05）。
The results showed that the levels of three tumor markers in ovarian cancer patients were significantly higher than those in benign tumor patients and controls(P<0. 05).
结论：卵巢癌组织中MIF蛋白表达上调导致巨噬细胞和自然杀伤细胞增多，可能是肿瘤进一步恶化的原因之一。
Conclusion the up-regulated expression of MIF can make the increase of macrophages and natural killer cells, it is one of the reasons of tumor development.
卵巢癌是最致命的恶性肿瘤之一，部分原因就是因为它常缺乏任何症状，等到被诊断的时候常常已经都是晚期。
Ovarian cancer is one of the most deadly cancers, in part because the symptoms are so vague that women often are not diagnosed until it is too late.
在晚期卵巢癌中评价以铂类药物为基础的新型治疗方案：妇科肿瘤研究团队II I期临床试验。
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic cancer Intergroup.
卵巢癌仍然是妇科恶性肿瘤疾病的主要死亡原因，并且大部分卵巢恶性肿瘤来自于卵巢表面上皮细胞。
Ovarian carcinoma continues to be the leading cause of death in malignant cancer of gynecology, which is almost derived from the ovarian surface epithelium.
方法：对1985 - 1998年间在广西肿瘤医院妇瘤科治疗的313例卵巢癌患者进行回顾性研究。
METHODS: a retrospective review was performed of 313 patients treated between 1985 and 1998 at the Department of female tumor of Guangxi tumor Hospital.
目的探讨肿瘤转移相关基因编码蛋白在卵巢癌和宫颈癌转移中的表达规律及其临床意义。
Objective To study the expression regularity and its significance of tumor metastasis related genes in tumor tissues of patients with ovarian or cervical cancer.
目的探讨肿瘤转移相关基因编码蛋白在卵巢癌和宫颈癌转移中的表达规律及其临床意义。
Objective To study the expression regularity and its significance of tumor metastasis related genes in tumor tissues of patients with ovarian or cervical cancer.
应用推荐